Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes.

Knowledge of the accurate copy number of HLA class I presented ligands is important in fundamental and clinical immunology. Currently, the best copy number determinations are based on mass spectrometry, employing single reaction monitoring (SRM) in combination with a known amount of isotopically labeled peptide. The major drawback of this approach is that the losses during sample pretreatment, i.e. immunopurification and filtration steps, are not well defined and must, therefore, be estimated. In addition, such losses can vary for individual peptides. Therefore, we developed a new approach in which isotopically labeled peptide-MHC monomers (hpMHC) are prepared and added directly after cell lysis, i.e. before the usual sample processing. Using this approach, all losses during sample processing can be accounted for and allows accurate determination of specific MHC class I-presented ligands. Our study pinpoints the immunopurification step as the origin of the rather extreme losses during sample pretreatment and offers a solution to account for these losses. Obviously, this has important implications for accurate HLA-ligand quantitation. The strategy presented here can be used to obtain a reliable view of epitope copy number and thus allows improvement of vaccine design and strategies for immunotherapy.

[1]  A. Wafelman,et al.  Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study , 2012, Haematologica.

[2]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[3]  J. Ritz,et al.  NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Jeanine J Houwing-Duistermaat,et al.  High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. , 2010, Cancer research.

[6]  N. Croft,et al.  Direct quantitation of MHC‐bound peptide epitopes by selected reaction monitoring , 2011, Proteomics.

[7]  J. Yewdell,et al.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.

[8]  L. Zhao,et al.  Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. , 2012, Blood.

[9]  Jennifer N. Sutton,et al.  Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members , 2005, Cancer Immunology, Immunotherapy.

[10]  S. H. van der Burg,et al.  Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. , 2009, The New England journal of medicine.

[11]  J. Leunissen,et al.  The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes* , 2013, Molecular & Cellular Proteomics.

[12]  J. Falkenburg,et al.  Graft versus leukemia reactivity after allogeneic stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  R. Givens,et al.  New derivatizing agents for amino acids and peptides. 1. Facile synthesis of N-substituted 1-cyanobenz[f]isoindoles and their spectroscopic properties , 1986 .

[14]  Jeffrey K. Mito,et al.  Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. , 2010, Blood.

[15]  J. Drijfhout,et al.  Discovery of T Cell Epitopes Implementing HLA-Peptidomics into a Reverse Immunology Approach , 2013, The Journal of Immunology.

[16]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[17]  J. McCluskey,et al.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire , 2012, Nature.

[18]  R. Schuster Determination of amino acids in biological, pharmaceutical, plant and food samples by automated precolumn derivatization and high-performance liquid chromatography. , 1988, Journal of chromatography.

[19]  Anthony W. Purcell,et al.  Kinetics of Antigen Expression and Epitope Presentation during Virus Infection , 2013, PLoS pathogens.